Helex Raises $3.5 Million in Seed Round Led by pi Ventures
Helex aims to develop a single-dose, gene-editing-based therapy that could potentially halt or significantly slow disease progression.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
